{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:12:02Z","timestamp":1793139122830,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":1782,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s13311-018-00684-2","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T17:18:08Z","timestamp":1541438288000},"page":"915-927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Myopathies Related to Glycogen Metabolism Disorders"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-3746","authenticated-orcid":false,"given":"Mark A.","family":"Tarnopolsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ymgme.2012.08.019","article-title":"Fat and carbohydrate metabolism during exercise in late-onset Pompe disease","volume":"107","author":"Preisler","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"4 Pt 1","key":"10.1007\/s13311-018-00684-2_bib2","first-page":"E733","article-title":"Exercise and insulin cause GLUT-4 translocation in human skeletal muscle","volume":"277","author":"Thorell","year":"1999","journal-title":"Am J Physiol"},{"issue":"6 Pt 1","key":"10.1007\/s13311-018-00684-2_bib3","first-page":"E1039","article-title":"Exercise regulation of glucose transport in skeletal muscle","volume":"273","author":"Hayashi","year":"1997","journal-title":"Am J Physiol"},{"issue":"9","key":"10.1007\/s13311-018-00684-2_bib4","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ajcn\/34.9.1831","article-title":"The role of dietary carbohydrates in muscle glycogen resynthesis after strenuous running","volume":"34","author":"Costill","year":"1981","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib5","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1152\/jappl.1995.78.4.1360","article-title":"Carbohydrate loading and metabolism during exercise in men and women","volume":"78","author":"Tarnopolsky","year":"1995","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0014-5793(74)80400-X","article-title":"Activation of muscle glycolysis: a role for creatine phosphate in phosphofructokinase regulation","volume":"46","author":"Storey","year":"1974","journal-title":"FEBS Lett"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/physiolgenomics.90217.2008","article-title":"PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4","volume":"35","author":"Benton","year":"2008","journal-title":"Physiol Genomics"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1152\/jappl.1993.75.2.712","article-title":"Human muscle metabolism during intermittent maximal exercise","volume":"75","author":"Gaitanos","year":"1993","journal-title":"J Appl Physiol (1985)"},{"issue":"9","key":"10.1007\/s13311-018-00684-2_bib9","first-page":"1009","article-title":"Carbohydrate dependence during marathon running","volume":"25","author":"O'Brien","year":"1993","journal-title":"Med Sci Sports Exerc"},{"issue":"3 Pt 1","key":"10.1007\/s13311-018-00684-2_bib10","first-page":"E380","article-title":"Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration","volume":"265","author":"Romijn","year":"1993","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1007\/s13311-018-00684-2_bib11","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1152\/jappl.2000.88.5.1707","article-title":"Substrate metabolism during different exercise intensities in endurance-trained women","volume":"88","author":"Romijn","year":"2000","journal-title":"J Appl Physiol (1985)"},{"issue":"9","key":"10.1007\/s13311-018-00684-2_bib12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms","volume":"59","author":"Haller","year":"2002","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1007\/s13311-018-00684-2_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrneph.2011.56","article-title":"Early fluid resuscitation in patients with rhabdomyolysis","volume":"7","author":"Better","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1007\/s13311-018-00684-2_bib14","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/gim.2015.9","article-title":"Determining the prevalence of McArdle disease from gene frequency by analysis of next-generation sequencing data","volume":"17","author":"De Castro","year":"2015","journal-title":"Genet Med"},{"issue":"Suppl 8","key":"10.1007\/s13311-018-00684-2_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1186\/s12864-017-4188-2","article-title":"Genotypic and phenotypic features of all Spanish patients with McArdle disease: a 2016 update","volume":"18","author":"Santalla","year":"2017","journal-title":"BMC Genomics"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","article-title":"Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry","volume":"83","author":"Lucia","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib17","first-page":"13","article-title":"Myopathy due to a defect in muscle glycogen breakdown","volume":"10","author":"Mc","year":"1951","journal-title":"Clin Sci"},{"key":"10.1007\/s13311-018-00684-2_bib18","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1002\/mus.880181416","article-title":"Myogenic hyperuricemia: what can we learn from metabolic myopathies?","volume":"3","author":"Mineo","year":"1995","journal-title":"Muscle Nerve Suppl"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.25588","article-title":"Novel variant in the PYGM gene causing late-onset limb-girdle myopathy, ptosis, and camptocormia","volume":"57","author":"Cheraud","year":"2018","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mus.10330","article-title":"Diagnostic utility of a modified forearm ischemic exercise test and technical issues relevant to exercise testing","volume":"27","author":"Tarnopolsky","year":"2003","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.10263","article-title":"A nonischemic forearm exercise test for McArdle disease","volume":"52","author":"Kazemi-Esfarjani","year":"2002","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ana.410280410","article-title":"Adult phosphorylase b kinase deficiency","volume":"28","author":"Clemens","year":"1990","journal-title":"Ann Neurol"},{"issue":"3 Pt 1","key":"10.1007\/s13311-018-00684-2_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1212\/WNL.44.3_Part_1.461","article-title":"Clinical and biochemical features of 10 adult patients with muscle phosphorylase kinase deficiency","volume":"44","author":"Wilkinson","year":"1994","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nmd.2009.11.004","article-title":"Muscle phosphorylase b kinase deficiency revisited","volume":"20","author":"Echaniz-Laguna","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.a.30517","article-title":"Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene","volume":"133A","author":"Wuyts","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"20","key":"10.1007\/s13311-018-00684-2_bib26","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.wnl.0000289190.66955.67","article-title":"Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?","volume":"70","author":"Orngreen","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.0b013e31824365f9","article-title":"Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease?","volume":"78","author":"Preisler","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1007\/s13311-018-00684-2_bib28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.ejhg.5200996","article-title":"Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases","volume":"11","author":"Burwinkel","year":"2003","journal-title":"Eur J Hum Genet"},{"issue":"1\u20132","key":"10.1007\/s13311-018-00684-2_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","article-title":"Glycogen storage disease type IX: high variability in clinical phenotype","volume":"92","author":"Beauchamp","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"11","key":"10.1007\/s13311-018-00684-2_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/jhg.2009.100","article-title":"Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p.R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations","volume":"54","author":"Aoyama","year":"2009","journal-title":"J Hum Genet"},{"issue":"11","key":"10.1007\/s13311-018-00684-2_bib31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10038-006-0045-x","article-title":"Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey","volume":"51","author":"Endo","year":"2006","journal-title":"J Hum Genet"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.10347","article-title":"Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area","volume":"109","author":"Lucchiari","year":"2002","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib33","first-page":"108","article-title":"Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan","volume":"106","author":"Okubo","year":"2000","journal-title":"Hum Genet"},{"issue":"11","key":"10.1007\/s13311-018-00684-2_bib34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-116-11-896","article-title":"Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy","volume":"116","author":"Coleman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1007\/s13311-018-00684-2_bib35","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archneur.1984.04050210025008","article-title":"Clinical varieties of neuromuscular disease in debrancher deficiency","volume":"41","author":"Cornelio","year":"1984","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jnnp.67.3.364","article-title":"Different clinical aspects of debrancher deficiency myopathy","volume":"67","author":"Kiechl","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1007\/s13311-018-00684-2_bib37","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/ana.410050504","article-title":"Debrancher deficiency: neuromuscular disorder in 5 adults","volume":"5","author":"DiMauro","year":"1979","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1007\/s13311-018-00684-2_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00314902","article-title":"Debrancher deficiency neuromuscular disorder with pseudohypertrophy in two brothers","volume":"236","author":"Marbini","year":"1989","journal-title":"J Neurol"},{"issue":"24","key":"10.1007\/s13311-018-00684-2_bib39","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1212\/WNL.0000000000004752","article-title":"Muscle glycogen synthesis and breakdown are both impaired in glycogenin-1 deficiency","volume":"89","author":"Stemmerik","year":"2017","journal-title":"Neurology"},{"issue":"13","key":"10.1007\/s13311-018-00684-2_bib40","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa0900661","article-title":"Glycogenin-1 deficiency and inactivated priming of glycogen synthesis","volume":"362","author":"Moslemi","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ana.24284","article-title":"A new muscle glycogen storage disease associated with glycogenin-1 deficiency","volume":"76","author":"Malfatti","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2015.10.012","article-title":"Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1","volume":"26","author":"Akman","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1007\/s13311-018-00684-2_bib43","first-page":"331","article-title":"The Jeremiah Metzger Lecture: gene therapy for inherited disorders: from Christmas disease to Leber's amaurosis","volume":"120","author":"High","year":"2009","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib44","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/0006-291X(70)90017-3","article-title":"Mitochondrial citric acid cycle and related enzymes: adaptive response to exercise","volume":"40","author":"Holloszy","year":"1970","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib45","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1212\/NXG.0000000000000208","article-title":"Clinical heterogeneity and phenotype\/genotype findings in 5 families with GYG1 deficiency","volume":"3","author":"Ben Yaou","year":"2017","journal-title":"Neurol Genet"},{"issue":"15","key":"10.1007\/s13311-018-00684-2_bib46","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","article-title":"Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0","volume":"357","author":"Kollberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2009.07.012","article-title":"Identification of a novel mutation in GYS1 (muscle-specific glycogen synthase) resulting in sudden cardiac death, that is diagnosable from skin fibroblasts","volume":"98","author":"Cameron","year":"2009","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1007\/s13311-018-00684-2_bib48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ygeno.2008.01.011","article-title":"Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis","volume":"91","author":"McCue","year":"2008","journal-title":"Genomics"},{"issue":"1 Pt A","key":"10.1007\/s13311-018-00684-2_bib49","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1016\/j.bbagen.2016.08.021","article-title":"A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase","volume":"1861","author":"Maile","year":"2017","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1172\/JCI118517","article-title":"Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene","volume":"97","author":"Bao","year":"1996","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib51","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1212\/01.WNL.0000138429.11433.0D","article-title":"Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV)","volume":"63","author":"Bruno","year":"2004","journal-title":"Neurology"},{"issue":"6\u20137","key":"10.1007\/s13311-018-00684-2_bib52","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0960-8966(99)00040-1","article-title":"A novel missense mutation in the glycogen branching enzyme gene in a child with myopathy and hepatopathy","volume":"9","author":"Bruno","year":"1999","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3476(87)80341-4","article-title":"Severe cardiopathy in branching enzyme deficiency","volume":"111","author":"Servidei","year":"1987","journal-title":"J Pediatr"},{"issue":"10","key":"10.1007\/s13311-018-00684-2_bib54","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.nmd.2016.07.005","article-title":"A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle","volume":"26","author":"Malfatti","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410330114","article-title":"Glycogen branching enzyme deficiency in adult polyglucosan body disease","volume":"33","author":"Bruno","year":"1993","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1007\/s13311-018-00684-2_bib56","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1007\/s00415-015-7859-4","article-title":"Frequent misdiagnosis of adult polyglucosan body disease","volume":"262","author":"Hellmann","year":"2015","journal-title":"J Neurol"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.43.4.785","article-title":"Polyglucosan body disease simulating amyotrophic lateral sclerosis","volume":"43","author":"McDonald","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2013.4888","article-title":"Branching enzyme deficiency: expanding the clinical spectrum","volume":"71","author":"Paradas","year":"2014","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib59","first-page":"105","article-title":"Tarui disease and distal glycogenoses: clinical and genetic update","volume":"26","author":"Toscano","year":"2007","journal-title":"Acta Myol"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib60","first-page":"305","article-title":"Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII\u2014and their population frequency","volume":"55","author":"Sherman","year":"1994","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ajh.2830140208","article-title":"Two cases of phosphofructokinase deficiency associated with congenital hemolytic anemia found in Japan","volume":"14","author":"Tani","year":"1983","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/bbrc.1994.1948","article-title":"A new variant of muscle phosphofructokinase deficiency in a Japanese case with abnormal RNA splicing","volume":"202","author":"Hamaguchi","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib63","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V71.4.1130.1130","article-title":"Erythrocyte glycolysis and its marked alterations by muscular exercise in type VII glycogenosis","volume":"71","author":"Shimizu","year":"1988","journal-title":"Blood"},{"key":"10.1007\/s13311-018-00684-2_bib64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0006-291X(65)90156-7","article-title":"Phosphofructokinase deficiency in skeletal muscle. a new type of glycogenosis","volume":"19","author":"Tarui","year":"1965","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.62.1.82","article-title":"No spontaneous second wind in muscle phosphofructokinase deficiency","volume":"62","author":"Haller","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nmd.2011.10.022","article-title":"Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII)","volume":"22","author":"Musumeci","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00270403","article-title":"Hereditary hemolytic anemia with erythrocyte phosphofructokinase deficiency: studies of some properties of erythrocyte and muscle enzyme","volume":"31","author":"Etiemble","year":"1976","journal-title":"Hum Genet"},{"key":"10.1007\/s13311-018-00684-2_bib68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fphys.2013.00393","article-title":"First description of phosphofructokinase deficiency in spain: identification of a novel homozygous missense mutation in the PFKM gene","volume":"4","author":"Vives-Corrons","year":"2013","journal-title":"Front Physiol"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib69","first-page":"205","article-title":"Muscle phosphofructokinase deficiency (Tarui's disease): report of a case","volume":"98","author":"Lin","year":"1999","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib70","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/ped.12616","article-title":"Infantile form of muscle phosphofructokinase deficiency in a premature neonate","volume":"57","author":"Wu","year":"2015","journal-title":"Pediatr Int"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib71","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.880150406","article-title":"Fatal familial infantile glycogen storage disease: multisystem phosphofructokinase deficiency","volume":"15","author":"Amit","year":"1992","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1007\/s13311-018-00684-2_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000615","article-title":"Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis","volume":"5","author":"Garcia","year":"2009","journal-title":"PLoS Genet"},{"issue":"11","key":"10.1007\/s13311-018-00684-2_bib73","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.36.11.1465","article-title":"Fatal infantile form of muscle phosphofructokinase deficiency","volume":"36","author":"Servidei","year":"1986","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.410130104","article-title":"Phosphoglycerate kinase deficiency: another cause of recurrent myoglobinuria","volume":"13","author":"DiMauro","year":"1983","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1468-1331.2000.00012.x","article-title":"Phosphoglycerate kinase deficiency in two brothers with McArdle-like clinical symptoms","volume":"7","author":"Aasly","year":"2000","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2006.06351.x","article-title":"PGK deficiency","volume":"136","author":"Beutler","year":"2007","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib77","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.V84.3.898.898","article-title":"Identification of new mutations in two phosphoglycerate kinase (PGK) variants expressing different clinical syndromes: PGK Creteil and PGK Amiens","volume":"84","author":"Cohen-Solal","year":"1994","journal-title":"Blood"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib78","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ymgme.2012.05.015","article-title":"A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization","volume":"106","author":"Fermo","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/088307388900400203","article-title":"Recurrent myoglobinuria in a child with mental retardation: phosphoglycerate kinase deficiency","volume":"4","author":"Sugie","year":"1989","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1007\/s13311-018-00684-2_bib80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/mus.20859","article-title":"Altered expression of PGK1 in a family with phosphoglycerate kinase deficiency","volume":"36","author":"Svaasand","year":"2007","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mus.23527","article-title":"Phosphoglycerate mutase deficiency with tubular aggregates in a patient from Panama","volume":"47","author":"Salameh","year":"2013","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1007\/s13311-018-00684-2_bib82","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.nmd.2016.08.002","article-title":"Phosphoglycerate mutase deficiency (glycogen storage disease X) caused by a novel variant in PGAM-M","volume":"26","author":"Koo","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"4500","key":"10.1007\/s13311-018-00684-2_bib83","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1126\/science.6262916","article-title":"Human muscle phosphoglycerate mutase deficiency: newly discovered metabolic myopathy","volume":"212","author":"DiMauro","year":"1981","journal-title":"Science"},{"key":"10.1007\/s13311-018-00684-2_bib84","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1002\/mus.880181412","article-title":"Molecular genetic studies in muscle phosphoglycerate mutase (PGAM-M) deficiency","volume":"3","author":"Tsujino","year":"1995","journal-title":"Muscle Nerve Suppl"},{"issue":"11","key":"10.1007\/s13311-018-00684-2_bib85","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nmd.2009.08.007","article-title":"Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M gene","volume":"19","author":"Tonin","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"9","key":"10.1007\/s13311-018-00684-2_bib86","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1134::AID-MUS8>3.0.CO;2-0","article-title":"Molecular basis of muscle phosphoglycerate mutase (PGAM-M) deficiency in the Italian kindred","volume":"19","author":"Toscano","year":"1996","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib87","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archneurol.2008.584","article-title":"Muscle phosphoglycerate mutase deficiency revisited","volume":"66","author":"Naini","year":"2009","journal-title":"Arch Neurol"},{"issue":"10","key":"10.1007\/s13311-018-00684-2_bib88","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2169\/internalmedicine.35.799","article-title":"Partial deficiency of phosphoglycerate mutase with diabetic polyneuropathy: the first Japanese patient","volume":"35","author":"Kawashima","year":"1996","journal-title":"Intern Med"},{"issue":"9","key":"10.1007\/s13311-018-00684-2_bib89","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/archneur.62.9.1440","article-title":"Effect of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency","volume":"62","author":"Vissing","year":"2005","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.1095","article-title":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","volume":"50","author":"Comi","year":"2001","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1007\/s13311-018-00684-2_bib91","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1007\/s00415-014-7512-7","article-title":"Recurrent rhabdomyolysis due to muscle beta-enolase deficiency: very rare or underestimated?","volume":"261","author":"Musumeci","year":"2014","journal-title":"J Neurol"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0009-8981(88)90359-2","article-title":"Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy","volume":"173","author":"Kanno","year":"1988","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1007\/s13311-018-00684-2_bib93","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0009-8981(80)90013-3","article-title":"Hereditary deficiency of lactate dehydrogenase M-subunit","volume":"108","author":"Kanno","year":"1980","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib94","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00204925","article-title":"Genotypic analysis of families with lactate dehydrogenase A (M) deficiency by selective DNA amplification","volume":"88","author":"Maekawa","year":"1991","journal-title":"Hum Genet"},{"key":"10.1007\/s13311-018-00684-2_bib95","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/mus.880181413","article-title":"Lactate dehydrogenase M-subunit deficiencies: clinical features, metabolic background, and genetic heterogeneities","volume":"3","author":"Kanno","year":"1995","journal-title":"Muscle Nerve Suppl"},{"issue":"5","key":"10.1007\/s13311-018-00684-2_bib96","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/WNL.51.5.1456","article-title":"Oral branched-chain amino acids do not improve exercise capacity in McArdle disease","volume":"51","author":"MacLean","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib97","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archneur.65.6.786","article-title":"Effect of oral sucrose shortly before exercise on work capacity in McArdle disease","volume":"65","author":"Andersen","year":"2008","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib98","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ana.20881","article-title":"Aerobic conditioning: an effective therapy in McArdle's disease","volume":"59","author":"Haller","year":"2006","journal-title":"Ann Neurol"},{"issue":"15","key":"10.1007\/s13311-018-00684-2_bib99","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.2169\/internalmedicine.49.3525","article-title":"A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis","volume":"49","author":"Izumi","year":"2010","journal-title":"Intern Med"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib100","first-page":"64","article-title":"Chronic therapy for McArdle disease: the randomized trial with ACE inhibitor","volume":"26","author":"Martinuzzi","year":"2007","journal-title":"Acta Myol"},{"key":"10.1007\/s13311-018-00684-2_bib101","article-title":"Physical training for McArdle disease","volume":"12","author":"Quinlivan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1007\/s13311-018-00684-2_bib102","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archneur.57.7.956","article-title":"Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial","volume":"57","author":"Vorgerd","year":"2000","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib103","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.59.1.97","article-title":"Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study","volume":"59","author":"Vorgerd","year":"2002","journal-title":"Arch Neurol"},{"issue":"26","key":"10.1007\/s13311-018-00684-2_bib104","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","article-title":"The effect of oral sucrose on exercise tolerance in patients with McArdle's disease","volume":"349","author":"Vissing","year":"2003","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1007\/s13311-018-00684-2_bib105","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.1989.03430170057028","article-title":"Physical fitness and all-cause mortality. A prospective study of healthy men and women","volume":"262","author":"Blair","year":"1989","journal-title":"JAMA"},{"issue":"16","key":"10.1007\/s13311-018-00684-2_bib106","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.282.16.1547","article-title":"Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men","volume":"282","author":"Wei","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/JSM.0b013e3180f6168c","article-title":"Favorable responses to acute and chronic exercise in McArdle patients","volume":"17","author":"Mate-Munoz","year":"2007","journal-title":"Clin J Sport Med"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib108","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/0883073812451328","article-title":"Resistance (weight lifting) training in an adolescent with McArdle disease","volume":"28","author":"Garcia-Benitez","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1007\/s13311-018-00684-2_bib109","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fnagi.2014.00334","article-title":"Feasibility of resistance training in adult McArdle patients: clinical outcomes and muscle strength and mass benefits","volume":"6","author":"Santalla","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1007\/s13311-018-00684-2_bib110","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphys.2015.00245","article-title":"Nutritional interventions to augment resistance training-induced skeletal muscle hypertrophy","volume":"6","author":"Morton","year":"2015","journal-title":"Front Physiol"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib111","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1056\/NEJM199102073240603","article-title":"Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency","volume":"324","author":"Haller","year":"1991","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1007\/s13311-018-00684-2_bib112","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1152\/jappl.1992.73.5.1986","article-title":"Evaluation of protein requirements for trained strength athletes","volume":"73","author":"Tarnopolsky","year":"1992","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib113","doi-asserted-by":"crossref","first-page":"E580","DOI":"10.1152\/ajpendo.2000.278.4.E580","article-title":"Endurance exercise training attenuates leucine oxidation and BCOAD activation during exercise in humans","volume":"278","author":"McKenzie","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib114","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJM198502073120607","article-title":"Myopathy in McArdle's syndrome. Improvement with a high-protein diet","volume":"312","author":"Slonim","year":"1985","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1007\/s13311-018-00684-2_bib115","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0002-8223(93)92246-T","article-title":"Nutrition therapy for hepatic glycogen storage diseases","volume":"93","author":"Goldberg","year":"1993","journal-title":"J Am Diet Assoc"},{"issue":"4","key":"10.1007\/s13311-018-00684-2_bib116","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ana.410110417","article-title":"Reversal of debrancher deficiency myopathy by the use of high-protein nutrition","volume":"11","author":"Slonim","year":"1982","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-018-00684-2_bib117","doi-asserted-by":"crossref","DOI":"10.1093\/advances\/nmy003","article-title":"Perspective: Protein requirements and optimal intakes in aging: are we ready to recommend more than the recommended daily allowance?","author":"Traylor","year":"2018","journal-title":"Adv Nutr"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib118","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archneurol.2009.93","article-title":"Effect of changes in fat availability on exercise capacity in McArdle disease","volume":"66","author":"Andersen","year":"2009","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1007\/s13311-018-00684-2_bib119","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/01.wnl.0000343002.74480.e4","article-title":"Fat metabolism during exercise in patients with McArdle disease","volume":"72","author":"Orngreen","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-018-00684-2_bib120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11940-008-0043-8","article-title":"The ketogenic diet: uses in epilepsy and other neurologic illnesses","volume":"10","author":"Baranano","year":"2008","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib121","first-page":"61","article-title":"Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle","volume":"26","author":"Vorgerd","year":"2007","journal-title":"Acta Myol"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib122","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mus.22290","article-title":"Confirmation of the efficacy of vitamin B6 supplementation for McArdle disease by follow-up muscle biopsy","volume":"45","author":"Sato","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1007\/s13311-018-00684-2_bib123","article-title":"Pharmacological and nutritional treatment for McArdle disease (glycogen storage disease type V)","volume":"11","author":"Quinlivan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1007\/s13311-018-00684-2_bib124","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1152\/jappl.1996.81.1.232","article-title":"Muscle creatine loading in men","volume":"81","author":"Hultman","year":"1996","journal-title":"J Appl Physiol (1985)"},{"key":"10.1007\/s13311-018-00684-2_bib125","article-title":"Creatine for treating muscle disorders","volume":"6","author":"Kley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2\u20133","key":"10.1007\/s13311-018-00684-2_bib126","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10545-006-0290-3","article-title":"Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential","volume":"29","author":"Roe","year":"2006","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"10.1007\/s13311-018-00684-2_bib127","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-017-0473-2","article-title":"Treatment opportunities in patients with metabolic myopathies","volume":"19","author":"Orngreen","year":"2017","journal-title":"Curr Treat Options Neurol"},{"issue":"8","key":"10.1007\/s13311-018-00684-2_bib128","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1194\/jlr.M075531","article-title":"Triacylglycerol mimetics regulate membrane interactions of glycogen branching enzyme: implications for therapy","volume":"58","author":"Alvarez","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1007\/s13311-018-00684-2_bib129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ymgmr.2017.05.009","article-title":"Higher oxidative stress in skeletal muscle of McArdle disease patients","volume":"12","author":"Kaczor","year":"2017","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"10.1007\/s13311-018-00684-2_bib130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ymgme.2013.06.022","article-title":"Oxidative stress and Nrf2 signaling in McArdle disease","volume":"110","author":"Kitaoka","year":"2013","journal-title":"Mol Genet Metab"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-00684-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-00684-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-00684-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T19:46:16Z","timestamp":1728675976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923010218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1878747923010218"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-00684-2","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myopathies Related to Glycogen Metabolism Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-00684-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}